Why Simple Digital Nudges Fail: A Cross-Domain Revelation
The promise of artificial intelligence in healthcare often conjures images of sophisticated algorithms predicting disease or optimizing complex treatment plans. Yet, a more fundamental, and…
Dermatology AI’s Dark Secret: Training Data Bias Risks Patient Safety
The promise of artificial intelligence in healthcare is vast, yet its deployment without rigorous scrutiny carries significant risks, particularly concerning equitable patient care. In dermatology,…
Akili: FDA Win, Commercial Fail. What Investors Missed.
The story of Akili Interactive, once hailed as a pioneer for its FDA-cleared video game therapy, and its subsequent workforce reductions and eventual acquisition, presents…
Noom’s Billion Dollar Valuation: The Missing Clinical Validation
The promise of AI in health is immense, yet the path to realizing its full potential is riddled with critical questions of safety, validation, and…
Hims & Hers: Billion Dollar Growth, Patient Safety Scrutiny
The burgeoning digital health market, exemplified by companies like Hims & Hers Health, presents a compelling paradox: exponential revenue growth alongside persistent questions regarding the…
Forward Health’s Fall: When Tech-First Ignores Clinical Validation
The November 2024 shutdown of Forward Health, a venture-backed primary care provider, after raising a staggering $650 million, sends a chilling message to both investors…
Pulse Oximeter Bias: A 30-Year Failure in Cardiac AI
The stark reality of algorithmic bias in healthcare is perhaps nowhere more tragically evident than in the case of pulse oximeters. Imagine a device, ubiquitous…
AI’s Billion-Dollar Blind Spot: The Algorithm That Failed 200M Patients
The promise of artificial intelligence in healthcare is vast, yet its deployment without rigorous scrutiny carries profound risks. A stark illustration of this danger emerged…
Teladoc’s 13 Billion Dollar Blunder: Integration Failure Lessons
The digital health landscape is littered with cautionary tales, but few resonate with the stark financial and clinical implications of Teladoc Health’s acquisition of Livongo.…
Olive AI’s Billion Dollar Bust: The Evidence-Free Fall of a Health AI Unicorn
The story of Olive AI is a cautionary tale for investors and health system CIOs navigating the burgeoning landscape of healthcare AI. Once heralded as…